Your browser doesn't support javascript.
loading
What about regular hematological monitoring during clozapine treatment? A compliance analysis using the French health insurance database.
Laforgue, Edouard-Jules; Istvan, Marion; Guerlais, Marylène; Chaslerie, Anicet; Artarit, Pascal; Vallot, Genevieve; Jolliet, Pascale; Grall-Bronnec, Marie; Victorri-Vigneau, Caroline.
Afiliação
  • Laforgue EJ; Clinical Pharmacology Department, Nantes University Hospital, Nantes, France.
  • Istvan M; INSERM UMR 1246 SPHERE (Methods in Patients-centered Outcomes and HEalth Research), Nantes and Tours Universities, France.
  • Guerlais M; Clinical Pharmacology Department, Nantes University Hospital, Nantes, France.
  • Chaslerie A; INSERM UMR 1246 SPHERE (Methods in Patients-centered Outcomes and HEalth Research), Nantes and Tours Universities, France.
  • Artarit P; Clinical Pharmacology Department, Nantes University Hospital, Nantes, France.
  • Vallot G; Medical Department, French Health Insurance System, Nantes, France.
  • Jolliet P; Medical Department, French Health Insurance System, Nantes, France.
  • Grall-Bronnec M; Medical Department, French Health Insurance System, Nantes, France.
  • Victorri-Vigneau C; Clinical Pharmacology Department, Nantes University Hospital, Nantes, France.
Expert Opin Drug Saf ; 20(10): 1247-1256, 2021 Oct.
Article em En | MEDLINE | ID: mdl-34085879
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antipsicóticos / Monitoramento de Medicamentos / Clozapina / Agranulocitose Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antipsicóticos / Monitoramento de Medicamentos / Clozapina / Agranulocitose Idioma: En Ano de publicação: 2021 Tipo de documento: Article